Global Medical Isotopes Competitive Landscape Professional Research Report 2024
Research Summary
Medical isotopes, also known as radiopharmaceuticals, are radioactive substances used in medical imaging, diagnosis, and therapy. These isotopes are typically produced in specialized nuclear reactors or particle accelerators. They are designed to emit radiation that can be detected and measured using imaging techniques such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), or gamma camera imaging. Medical isotopes are essential in various medical procedures, including the diagnosis and staging of diseases like cancer, evaluation of organ function and blood flow, and targeted therapy for certain conditions. Some commonly used medical isotopes include technetium-99m, iodine-131, and fluorine-18. The production, handling, and use of medical isotopes require strict safety protocols and regulations to protect both patients and healthcare professionals.
According to DIResearch's in-depth investigation and research, the global Medical Isotopes market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.
The major global manufacturers of Medical Isotopes include NRG, NTP Radioisotopes, JSC Isotope, ANSTO, IRE, Nordion, Curium Pharma, Cambridge Isotope Laboratories, Eckert & Ziegler Strahlen, Polatom, Center of Molecular Research, China National Nuclear Corporation, Urenco, LANL, Shanghai Engineering Research Center, IDB Holland, NHTC, Linde, SI Science, ORNL etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Medical Isotopes. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Medical Isotopes market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Medical Isotopes market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Medical Isotopes industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Medical Isotopes Include:
NRG
NTP Radioisotopes
JSC Isotope
ANSTO
IRE
Nordion
Curium Pharma
Cambridge Isotope Laboratories
Eckert & Ziegler Strahlen
Polatom
Center of Molecular Research
China National Nuclear Corporation
Urenco
LANL
Shanghai Engineering Research Center
IDB Holland
NHTC
Linde
SI Science
ORNL
Medical Isotopes Product Segment Include:
Stable Isotopes
Radioisotopes
Medical Isotopes Product Application Include:
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Medical Isotopes Industry PESTEL Analysis
Chapter 3: Global Medical Isotopes Industry Porter’s Five Forces Analysis
Chapter 4: Global Medical Isotopes Major Regional Market Size and Forecast Analysis
Chapter 5: Global Medical Isotopes Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Medical Isotopes Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Medical Isotopes Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Medical Isotopes Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Medical Isotopes Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Medical Isotopes Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Medical Isotopes Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Medical Isotopes Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources